Sakar Healthcare Ltd
Sakar Healthcare Ltd Share Price Today: Live Updates & Key Insights
Get insights on Sakar Healthcare Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Sakar Healthcare Ltd Share Price Chart
Sakar Healthcare Ltd Fundamentals
Traded Volume: 24,810
Market Cap(Cr): 829
Avg Traded Price 376.80
1 Year return 30.74%
Upper Circuit 391.8
Lower Circuit 368.6
P/E TTM 42.00
P/B Ratio 9.00
Traded Value(Cr) 92.39
EPS TTM 8.766
Book value 8.766
Dividend 0.00%
Sakar Healthcare Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Sakar Healthcare Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Sakar Healthcare Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -7.11%
1M +2.04%
3M +16.14%
1Y +30.74%
YTD +29.81%
Sakar Healthcare Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Sakar Healthcare Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 12758.00
Day Before Yesterday 20679.00
1W Avg 14735.20
1M Avg 34795.38
3M Avg 23658.02
Sakar Healthcare Ltd Technical Details
Sakar Healthcare Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 363
Support 2 354
Support 3 340
Pivot Point : 378
Resistance 1 387
Resistance 2 401
Resistance 3 410
Sakar Healthcare Ltd Corporate Actions
Sakar Healthcare Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Sakar Healthcare Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by SAKAR
Bonus
No Bonus has been declared by SAKAR
Splits
No Split has been declared by SAKAR
Others
Rights No Rights has been declared by SAKAR
Sakar Healthcare Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Sakar Healthcare Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Sakar Healthcare Ltd's relative performance and valuation against major competitors.
Stock Name Venus Remedies Ltd ₹700.95 (+1.72%) M. Cap (Cr) 9.37 1 Yr Return (%) +134.71% P/E (TTM) 13.32 PB Ratio 1.67
Stock Name Fredun Pharmaceuticals Ltd ₹1888.00 (-2.94%) M. Cap (Cr) 8.91 1 Yr Return (%) +180.95% P/E (TTM) 30.44 PB Ratio 6.72
Stock Name NGL Fine Chem Ltd ₹1348.00 (-3.15%) M. Cap (Cr) 8.33 1 Yr Return (%) -24.97% P/E (TTM) 40.26 PB Ratio 2.95
Stock Name Sakar Healthcare Ltd ₹372.40 (-4.88%) M. Cap (Cr) 8.29 1 Yr Return (%) +30.74% P/E (TTM) 42.48 PB Ratio 3.13
Stock Name Anlon Healthcare Ltd ₹155.06 (-0.81%) M. Cap (Cr) 8.24 1 Yr Return (%) NaN% P/E (TTM) PB Ratio 8.79
Stock Name Ind-Swift Laboratories Ltd ₹100.56 (+5.53%) M. Cap (Cr) 8.21 1 Yr Return (%) -2.09% P/E (TTM) 3.43 PB Ratio 0.79
Stock Name Fermenta Biotech Ltd ₹277.00 (-0.56%) M. Cap (Cr) 8.15 1 Yr Return (%) -15.25% P/E (TTM) 7.32 PB Ratio 2.83
Sakar Healthcare Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Sakar Healthcare Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 34.03 Mar 2024 24.47 Mar 2023 33.34 Mar 2022 35.79 Mar 2021 14.58
PARTICULARS Investing Activities Mar 2025 -30.71 Mar 2024 -51.54 Mar 2023 -74.38 Mar 2022 -90.40 Mar 2021 -46.83
PARTICULARS Financing Activities Mar 2025 -3.48 Mar 2024 27.44 Mar 2023 41.10 Mar 2022 54.56 Mar 2021 32.03
PARTICULARS Net Cash Flow Mar 2025 -0.16 Mar 2024 0.37 Mar 2023 0.06 Mar 2022 -0.05 Mar 2021 -0.22
Sakar Healthcare Ltd Shareholding Pattern
This shows the ownership breakdown of Sakar Healthcare Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 52.86%
Public 22.41%
Other Institutions 11.43%
FII 13.31%
Mutual Funds null%
About Sakar Healthcare Ltd
Sakar Healthcare Limited was incorporated as a Private Limited Company under the name Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHO-GMP, CGMP & National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote d'ivoire.In 2005, the Company started commercial production for Plant - 1 which was established for production of Liquid Orals; in 2007, it started exporting its products overseas; started commercial production for Plant - 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup B-lactum. / Sachet in 2008. Further, it started commercial production for Plant - 3 which was established for production of Liquid Injectibles (SVP) - Ampoules and Liquid Injectibles (SVP) - Vials.In 2012, it started commercial production for Plant - 4 which was established for production of Dry Powder Injection. In 2017, it started Lyophilised injection product commercialisation.In 2020, the Company received EU GMP certification for SVP unit manufacturing liquid and Lyophilised injections. In 2021, the Oncology Unit started operations in Bavla location. In 2022-23, the Company started commercialization with Oncology product post receiving WHO GMP certification.
Chairman & Managing Director
Sanjay S Shah.
Registered office 10/13 Nr MN Desai Petrol Pump, Sarkhej Bavla Highway, Changodar, Gujarat, 382213
FAX :91-2717-250477
Background
Incorporation Year 2004
Face Value ₹10.00
Market Lot 1
FAQs on Sakar Healthcare Ltd
How to buy Sakar Healthcare Ltd shares on NSE?
To buy Sakar Healthcare Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Sakar Healthcare Ltd share price today?
The Sakar Healthcare Ltd share price on NSE is ₹372.40 today.
What is the market cap of Sakar Healthcare Ltd on NSE?
The company has a market capitalization of ₹828.59.
What is the PE & PB ratio of Sakar Healthcare Ltd?
PE is 42 and PB is 9.
What is the 52 Week High and Low of Sakar Healthcare Ltd shares?
Sakar Healthcare Ltd stock price high: ₹411.80 Sakar Healthcare Ltd stock price low: ₹210.10.